Sera Prognostics, Inc. (NASDAQ:SERA) Insider Robert Gardner Harrison Sells 14,209 Shares

Sera Prognostics, Inc. (NASDAQ:SERA) insider Robert Gardner Harrison sold 14,209 shares of the company’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $7.39, for a total transaction of $105,004.51. Following the completion of the transaction, the insider now owns 116,837 shares in the company, valued at $863,425.43. This trade represents a 10.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Robert Gardner Harrison also recently made the following trade(s):

• On Monday, January 13th, Robert Gardner Harrison sold 2,264 shares of Sera Prognostics stock. The shares were sold at an average price of $6.47, for a total transaction of $14,648.08.

Sera Prognostics Price Performance

Shares of NASDAQ:SERA opened at $6.37 on Wednesday. The company has a market capitalization of $215.13 million, a P/E ratio of -6.43 and a beta of 0.86. The business’s 50 day simple moving average is $7.44 and its 200 day simple moving average is $7.31. Sera Prognostics, Inc. has a 1 year low of $4.98 and a 1 year high of $12.35.

Sera Prognostics (NASDAQ:SERA) last issued its quarterly earnings results on Wednesday, November 6th. The company reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.02). The company had revenue of $0.03 million during the quarter, compared to the consensus estimate of $0.09 million. During the same quarter in the prior year, the firm earned ($0.23) EPS. On average, sell-side analysts anticipate that Sera Prognostics, Inc. will post -0.96 EPS for the current fiscal year.

Hedge Funds Weigh In On Sera Prognostics

Several hedge funds have recently bought and sold shares of the company. Jane Street Group LLC lifted its holdings in shares of Sera Prognostics by 24.8% during the 3rd quarter. Jane Street Group LLC now owns 14,225 shares of the company’s stock worth $111,000 after acquiring an additional 2,826 shares during the period. American Century Companies Inc. raised its position in Sera Prognostics by 12.7% during the second quarter. American Century Companies Inc. now owns 25,682 shares of the company’s stock valued at $152,000 after purchasing an additional 2,891 shares in the last quarter. Quest Partners LLC lifted its stake in Sera Prognostics by 533.5% during the third quarter. Quest Partners LLC now owns 6,430 shares of the company’s stock worth $50,000 after purchasing an additional 5,415 shares during the last quarter. MetLife Investment Management LLC boosted its holdings in shares of Sera Prognostics by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 17,254 shares of the company’s stock valued at $135,000 after purchasing an additional 9,722 shares in the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Sera Prognostics in the 3rd quarter valued at $78,000. 54.64% of the stock is owned by institutional investors.

About Sera Prognostics

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.